Title: Patent WO 2013014448 A1. 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer.
1421372-67-9
1421373-65-0
1421373-98-9
1594092-37-1
2134096-03-8
1421373-36-5
816425-22-6 | (R)-2-(Pyrrolidin-2-yl)propan-2-ol hydrochloride | AA0039FB | MFCD27952815
953045-91-5 | 7-Chloro-3-methylthieno[3,2-b]pyridine | AA0039IO | MFCD17016056
641-70-3 | 3-Nitrophthalic anhydride | AA0039LU | MFCD00005921
56181-49-8 | 2-Bromo-4,6-diphenylpyrimidine | AA0039P4 | MFCD00234884
36309-88-3 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) dichloride | AA0039S8 | MFCD03095387
642-91-1 | 2,1-Benzisoxazole-3-carboxylic acid | AA0039W1 | MFCD02180526
33419-42-0 | Etoposide | AA003A03 | MFCD00869325
6267-02-3 | 9,9-Dimethyl-9,10-dihydroacridine | AA003A3Z | MFCD00030130
912545-86-9 | Sag | AA003A7G | MFCD22581513
1857417-10-7 | Mi-538 | AA003AAO | MFCD30532690